The Hartford Balanced Income Fund Class R6

The Hartford Balanced Income Fund Class R6

HBLVX
The Hartford Balanced Income Fund Class R6US flagNASDAQ
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
The Hartford Balanced Income Fund Class R6 (HBLVX) is an open-end mutual fund that seeks current income with growth of capital as a secondary objective by investing in a balanced portfolio targeting approximately 45% equity securities and 55% fixed-income investments, with allocations generally varying by no more than +/-5%; the equity portion emphasizes large-cap value dividend-paying stocks, while the fixed-income sleeve focuses on investment-grade bonds including U.S. Treasuries, corporate bonds, and non-U.S. bonds. Share classes include A (HBLAX), C (HBLCX), F (HBLFX), I (HBLIX), R3 (HBLRX), R4 (HBLSX), R5 (HBLTX), R6 (HBLVX), and Y (HBLYX), with the fund domiciled in the United States and available primarily to U.S. investors through retirement plans and other institutional channels. The fund, subadvised by Wellington Management since inception, maintains a portfolio with 76 equity holdings (e.g., Bank of America Corp., Johnson & Johnson, Merck & Co Inc.), 591 fixed-income issuers, a net expense ratio of 0.56% for the R6 class, quarterly dividend frequency, and total net assets exceeding $11.67 billion as of late 2025. Managed primarily by Scott St. John (fixed-income sleeve, since 2006), Matthew Hand (equity sleeve, since 2019), and Adam Illfelder (equity support, since 2019), the fund operates within the Morningstar Moderately Conservative Allocation category and features low turnover of 61%, a beta of 0.60, and a yield to worst of 5.17%. Portfolio diversification spans U.S. bonds (41.52%), U.S. stocks (39.05%), non-U.S. bonds (12.67%), non-U.S. stocks (3.42%), and cash/other (3.32%), with top sectors including financial services, healthcare, industrials, technology, and energy; geographic focus is predominantly United States, with limited exposure to Eurozone, United Kingdom, and Europe ex-Euro. The Hartford Funds, issuer of HBLVX and founded around 1996 as a subsidiary of The Hartford Financial Services Group Inc. (established 1810), is headquartered in Wayne, Pennsylvania, and leverages subadvisory partnerships with Wellington Management (founded 1928) for independent research across asset classes. The R6 share class launched on November 7, 2014, with geographic operations centered in the U.S. market serving institutional and retirement investors seeking income and moderate growth. In a significant recent development, Noah C. Atlas joined the portfolio management team on September 30, 2025, as a fixed-income specialist from Wellington Management (since 2015), bolstering support for lead manager Scott St. John while existing managers Matthew Hand and Adam Illfelder continue leading equity strategies; this enlargement maintains the fund's disciplined income-focused approach without altering its Above Average People rating. On December 17, 2025, Hartford Funds announced the launch of its first options overlay strategy ETF (HEMI), highlighting ongoing innovation in collaboration with Wellington Management, though not directly impacting HBLVX operations. No major acquisitions, funding rounds, or strategic shifts specific to the fund were reported in the last 1-2 years.